Related Topics: Science & Technology, Antimicrobial Resistance
- India has joined the Global Antimicrobial Resistance (AMR) Research and Development (R&D) Hub as a new member.
- This expanded the global partnership working to address challenges and improve coordination and collaboration in global AMR R&D to 16 countries, the European Commission, two philanthropic foundations and four international organisations (as observers).
Why India Joined Global AMR R&D Hub?
- Antimicrobial resistance is a serious threat to global public health that requires action across all government sectors and society and is driven by many interconnected factors.
- Single, isolated interventions have limited impact and coordinated action is required to minimize the emergence and spread of antimicrobial resistance.
- By partnering with the Global AMR R&D Hub, India looks forward to working with all partners to leverage their existing capabilities, resources and collectively focus on new R&D intervention to address drug resistant infections.
- Given the important and interdependent human, animal, and environmental dimensions of antimicrobial resistance, India considers it reasonable to explore issues of antimicrobial resistance through the lens of One Health approach which should be supported by long-term commitments from all stakeholders.
About Global AMR R&D Hub
- The Global AMR R&D Hub was launched in May 2018 in the margins of the 71st session of the World Health Assembly, following a call from G20 Leaders in 2017.
- The Global AMR R&D Hub supports global priority setting and evidence-based decision-making on the allocation of resources for AMR R&D through the identification of gaps, overlaps and potential for cross-sectoral collaboration and leveraging in AMR R&D.
- The operation of the Global AMR R&D Hub is supported through a Secretariat, established in Berlin.
- It is currently financed through grants from the German Federal Ministry of Education and Research (BMBF) and the Federal Ministry of Health (BMG).